文献速递母胎医学

血管闭合装置封堵子宫进入部位的可行性与效力:妊娠绵羊模型的初步结果

Feasibility and efficacy of vascular closure device for sealing uterine entry site: preliminary results from pregnant sheep model.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-08-22

本研究在妊娠绵羊模型上评估Abbott Perclose™血管闭合装置用于胎儿镜手术子宫进入部位经羊膜经子宫缝合的可行性与潜在效力,于2023年12月至2025年2月开展,共纳入10只妊娠绵羊。结果显示75%(24/32)的装置放置成功,所有缝线在两次干预轮次、剖宫产时及原位均观察到水密闭合,组织病理学证实装置进入部位周围机化性纤维化及Cx43过表达。作者认为该装置作为子宫端口闭合的新方法在临床前绵羊模型中可行且具有潜在效力。

要点

  • 10只妊娠绵羊中4只为双胎妊娠,共使用32个Perclose装置,75%(24/32)放置成功。
  • 所有缝线在第一次和第二次干预轮次、剖宫产时及原位均观察到水密闭合。
  • 组织病理学证实装置进入部位周围机化性纤维化及Cx43过表达。

核心结论

  • 采用多种正交方法首次证明,Perclose装置作为胎儿镜手术子宫端口闭合的新方法在临床前绵羊模型中可行且具有潜在效力。
  • 作者预期临床验证研究将提供转化数据及直接测量减少绒毛膜羊膜分离、未足月胎膜早破和早产效力的手段。

研究设计与样本

  • 本研究采用妊娠绵羊模型模拟胎儿手术,于2023年12月至2025年2月开展。
  • 使用Abbott Perclose™血管闭合装置,在插入外径12-French套管之前或之后缝合子宫进入部位的胎膜。
  • 可行性定义为两个独立手术团队在两个不同孕龄成功放置缝线。
  • 潜在效力通过活体大体检查中进入部位的水密闭合以及产后组织病理学评估显示的胎膜和子宫肌层机化性纤维化和愈合来证明。
  • 手术在绵羊妊娠期分两个阶段进行,采用三种腹部进入途径接近子宫:中线剖腹术及直接子宫进入、2-cm迷你剖腹术进入子宫、经皮途径。

主要发现

  • 共纳入10只妊娠绵羊,其中4只为双胎妊娠。
  • 第一次和第二次干预轮次发生时的中位孕龄分别为85.5天和104天。
  • 共使用32个Perclose装置,75%(24/32)放置成功。
  • 在第一次和第二次干预轮次、剖宫产时及原位均观察到所有缝线的水密闭合。
  • 组织病理学检查证实装置进入部位周围机化性纤维化,此外Cx43过表达。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Membrane damage at or near the uterine entry site is a prevalent complication of fetal surgery and may result in chorioamniotic separation (CAS), preterm prelabor rupture of membranes (PPROM) and preterm birth. Transamniotic transuterine suturing approaches offer the potential to reduce the prevalence of CAS and PPROM accompanying fetoscopy, with the overarching aim of reducing preterm birth. This study aimed to explore the feasibility and potential efficacy of employing a novel vascular closure device for transamniotic transuterine suturing in a sheep model of fetoscopic surgery. METHODS: This study employed a pregnant sheep model to simulate fetal surgery and was conducted between December 2023 and February 2025. We used multiple methodologies to evaluate the Abbott Perclose™ vascular closure device for suturing membranes at the uterine entry site before or after the insertion of a 12-French outer diameter cannula. Feasibility was defined as successful suture placement by two independent surgical teams at two different gestational ages. Potential efficacy was demonstrated by the watertight closure of the entry site during in-vivo gross examination, along with organizing fibrosis and healing of membranes and myometrium, as assessed by postdelivery histopathological evaluation. The procedures were conducted in two phases during the sheep's gestation. Three approaches were used for abdominal entry to access the uterus: midline laparotomy and direct uterine entry; 2-cm mini laparotomy allowing access to the uterus; and a percutaneous approach. Histopathological examination of samples from the entry sites was conducted using routine microscopy, trichrome staining and immunohistochemistry for Connexin 43 (Cx43). This study was approved by the Institutional Animal Care and Use Committee (AN-2010). RESULTS: Ten pregnant sheep were included in this study, four of which had a twin pregnancy. The median gestational age at the occurrence of the first and second rounds of intervention was 85.5 and 104 days, respectively. Overall, 32 Perclose devices were used, and 75% (24/32) were placed successfully. Watertight closure of all sutures was observed during the first and second rounds of intervention, at Cesarean delivery and in situ. Histopathological examination confirmed organizing fibrosis surrounding the device entry site, in addition to overexpression of Cx43. CONCLUSIONS: Employing multiple orthogonal approaches, we have shown for the first time that the Perclose device is both feasible and potentially efficacious as a novel means of uterine port closure in our preclinical sheep model of fetoscopic surgery. Inspired by our success in this preclinical model, we anticipate that clinical validation studies will provide translational data and a direct means of measuring efficacy in the reduction of CAS, PPROM and preterm birth. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Krispin E, Qaderi S, Javinani A, et al. Feasibility and efficacy of vascular closure device for sealing uterine entry site: preliminary results from pregnant sheep model. Ultrasound Obstet Gynecol. 2025. PMID: 40843471. doi:10.1002/uog.70012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。